Sarepta Therapeutics, Inc.
SRPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $235,239 | -$535,977 | -$703,488 | -$418,780 |
| Dep. & Amort. | $37,724 | $44,397 | $41,864 | $38,017 |
| Deferred Tax | $0 | $0 | $0 | $15,813 |
| Stock-Based Comp. | $184,300 | $182,514 | $233,018 | $113,943 |
| Change in WC | -$716,606 | -$481,089 | -$39,470 | -$98,166 |
| Other Non-Cash | $53,556 | $289,162 | $142,730 | -$93,999 |
| Operating Cash Flow | -$205,787 | -$500,993 | -$325,346 | -$443,172 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$136,956 | -$76,106 | -$30,824 | -$38,490 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$1,099,595 | -$2,048,940 | -$1,937,856 | -$29,988 |
| Inv. Sales/Matur. | $2,002,112 | $1,868,482 | $923,224 | $466,000 |
| Other Inv. Act. | -$10,000 | $90,761 | -$1,427 | $97,891 |
| Investing Cash Flow | $755,561 | -$165,803 | -$1,046,883 | $495,413 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$68 | $0 | $304,168 | $0 |
| Stock Issued | $79,525 | $0 | $0 | $548,532 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $45,349 | $125,004 | -$71,661 | $13,037 |
| Financing Cash Flow | $124,806 | $125,004 | $232,507 | $561,569 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $674,580 | -$541,792 | -$1,139,722 | $613,810 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $444,009 | $985,801 | $2,125,523 | $1,511,713 |
| End Cash | $1,118,589 | $444,009 | $985,801 | $2,125,523 |
| Free Cash Flow | -$342,743 | -$588,338 | -$357,597 | -$481,662 |